Selank withdrawal and stopping: what actually happens

Last updated 2026-07-30

does selank cause withdrawal symptoms when you stop?

Short answer: there's no published evidence of a defined withdrawal syndrome for selank in humans. That's different from saying "it's proven safe to stop cold turkey." It means the studies that would tell us definitively don't exist yet. Selank is a heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, based on a fragment of tuftsin ^[1]. The Russian clinical work on it, mostly published in journals like Neuroscience and Behavioral Physiology and Zhurnal Nevrologii i Psikhiatrii, focuses on anxiolytic effects during use, not on discontinuation effects afterward. That's a meaningful gap. A drug can look completely clean in short trials and still produce rebound symptoms that only show up when researchers specifically design a study to look for them, and nobody has done that study for selank. What we do have is mechanistic reasoning. Selank isn't a benzodiazepine and doesn't act primarily through GABA-A receptor potentiation, which is the mechanism behind classic benzo withdrawal (rebound anxiety, seizures in severe cases, autonomic symptoms). Selank's proposed mechanisms involve modulation of BDNF expression, serotonergic activity, and enkephalin degradation (it inhibits enkephalin-degrading enzymes) ^[2]. None of those mechanisms are known to produce the kind of receptor downregulation that drives classic pharmacological withdrawal. That's reassuring in theory. It is not proof, because theory isn't data.

is selank withdrawal the same as benzodiazepine or SSRI withdrawal?

No, and conflating the two is one of the more common mistakes people make when researching this. Benzodiazepine withdrawal is a well-characterized, dangerous phenomenon with a real evidence base: physical dependence can develop within weeks of regular use, and abrupt discontinuation can cause rebound anxiety, insomnia, tremor, and in severe cases seizures ^[3]. SSRI discontinuation syndrome is also documented, typically involving dizziness, "brain zaps," irritability, and flu-like symptoms starting within days of stopping, especially with shorter half-life drugs like paroxetine ^[4]. Selank has neither of these documented patterns in the literature. It's not a controlled substance in the US or Russia, and Russian prescribing information doesn't carry warnings about physical dependence or withdrawal in the way benzodiazepine labeling does ^[1]. That absence of warnings isn't the same as an active declaration of safety on discontinuation. It just means nobody has flagged it as a problem in the trials that exist, and those trials weren't built to catch subtle rebound effects over weeks. If you're comparing selank to something you've taken before, benzodiazepines and SSRIs are the wrong comparison class. A better mental model is something closer to a supplement or a mild nootropic: probably fine to stop, unlikely to cause acute problems, but under-studied enough that "probably" is doing real work in that sentence.

what does the russian research actually say about stopping selank?

Almost nothing, directly. This is worth being blunt about because it's the single most useful thing to understand before you decide how to stop. The published Russian studies on selank are mostly short-duration trials, generally 2 to 4 weeks, looking at anxiety symptom scores (using instruments like the Spielberger-Hamilton scales) during active dosing in patients with generalized anxiety disorder or neurotic disorders ^[5][6]. A frequently cited study by Kozlovskaya and colleagues and later work summarized in review articles describe anxiolytic effects comparable to low-dose benzodiazepines without the sedation, but these papers report on-treatment outcomes. They do not report structured follow-up after the drug is stopped, and none of the widely cited papers include a washout period specifically designed to detect rebound anxiety or discontinuation symptoms. This matters for two reasons. First, absence of reported withdrawal in a 3-week trial doesn't rule out symptoms that might emerge over a longer period of use, because nobody has run a long trial with a real discontinuation arm. Second, most of this literature was never replicated in Western, peer-reviewed, English-language journals with the kind of sample sizes and blinding that would satisfy an FDA reviewer. That's not an insult to the Russian researchers; some of the work is methodologically reasonable for its era and setting. But it's also not the evidentiary bar that Western regulators or most clinicians would want before making firm claims about a discontinuation profile. If you want the fuller picture on how solid this evidence base is generally, the selank reviews piece and the selank success rate breakdown go through the study quality in more depth.

how long does it take for selank's effects to wear off after the last dose?

Based on pharmacokinetic data, not very long. Selank has a short half-life once it crosses into circulation, generally cited in the range of a few minutes to under an hour in animal pharmacokinetic studies, though human PK data specific to selank is sparse ^[7]. Peptides like this tend to get broken down quickly by peptidases in blood and tissue. That short half-life is actually one of the better arguments against expecting a dramatic withdrawal syndrome. Drugs that build up strong physical dependence tend to have either long dosing histories with receptor adaptation (opioids, benzos) or mechanisms that directly reshape receptor density over time. Selank's rapid clearance and its indirect, modulatory mechanism (affecting enzyme activity and gene expression rather than directly occupying a receptor continuously) don't match that pattern. In practice, most anecdotal reports (forum posts, informal user reports, nothing peer-reviewed) describe effects fading within a day of the last dose, with mood and anxiety levels returning to whatever baseline the person had before starting. Nobody has systematically tracked this in a study, so treat that as a loose pattern, not a guarantee.

can you stop selank cold turkey, or do you need to taper?

There's no clinical guideline, Russian or Western, that mandates a taper for selank. Russian product information for selank (marketed there under the brand name Selank, produced as a nasal spray) doesn't include taper instructions the way you'd see for a benzodiazepine or a corticosteroid ^[1]. That said, a taper costs you almost nothing and removes a variable you don't need to worry about. If you've been using selank daily for more than a few weeks, stepping down over 3 to 7 days (reducing dose frequency rather than dropping to zero the next day) is a reasonable, low-risk approach. It's not because the literature shows rebound symptoms. It's because when the evidence base is this thin, a slow stop is cheap insurance against something nobody has specifically ruled out. If you've only used it for a short course, a few days to two weeks, there's even less reason to think a taper matters. Most people in that position just stop and don't report anything notable. If you do notice anything unusual after stopping (see the next section), that's more useful information than any taper schedule, because it's your own actual data point in a research area that doesn't have much of it.

what withdrawal or rebound symptoms have people actually reported?

The honest answer is: essentially none that are well documented. There isn't a case series, an adverse event registry entry, or a published report describing a selank discontinuation syndrome. That absence could mean it doesn't happen, or it could mean nobody has looked hard enough, and with a substance this under-studied you can't fully distinguish those two possibilities. What does show up informally, in forums and user reports rather than in journals, is occasionally a return of the original anxiety symptoms the person was using selank to manage. That's not withdrawal in the pharmacological sense; that's the underlying condition reasserting itself once the drug (or the placebo effect, or the routine of taking something) is gone. It's the same pattern you'd expect from stopping almost any anxiolytic, including ones with no dependence liability at all, like buspirone. If you're tracking your own experience, the practical distinction is timing and pattern. Symptoms that emerge within a day or two of stopping and mirror what you had before starting are more likely baseline anxiety returning. Symptoms that are new, more severe than your baseline, or accompanied by things like tremor, sweating, or a racing heart would be unusual for selank and worth mentioning to a doctor, because they're not part of any pattern described in the existing literature. For a fuller sense of what people report during use versus after stopping, selank before and after and selank results timeline cover the on-treatment side of this in more detail.

is selank physically addictive or habit-forming?

There's no evidence in the published literature of physical dependence, tolerance requiring dose escalation, or drug-seeking behavior associated with selank. It's not scheduled as a controlled substance in the United States, and Russian regulatory materials don't classify it as habit-forming ^[1]. That's a meaningfully different question from psychological habituation, which can happen with almost anything you take daily as part of a routine, whether it's a peptide, caffeine, or a multivitamin. Feeling like you "need" your morning dose because it's part of your ritual isn't the same as physical dependence, and it doesn't require a medical taper to break. The more relevant caveat here isn't addiction risk, it's that we don't have long-term safety data at all. Most Russian trials run weeks, not years ^[5][6]. Nobody has published data on people using selank continuously for a year or more and then stopping. If you're a long-term daily user, that's the honest gap: not "is it addictive" (probably not, based on what exists) but "what happens with years of use" (genuinely unknown).

how is selank withdrawal different from semax withdrawal?

People frequently lump selank and semax together because they're sibling peptides from the same Russian research lineage (both developed with involvement from the Institute of Molecular Genetics), sold in similar nasal spray formats, and often discussed in the same breath online. But they're structurally and functionally distinct, and that matters for a stopping-and-withdrawal question specifically. Semax is derived from a fragment of ACTH (adrenocorticotropic hormone) and is studied primarily as a nootropic and neuroprotective agent, including research on stroke recovery and cognitive function ^[8]. Selank is derived from tuftsin and is studied primarily as an anxiolytic. Different peptide backbone, different primary mechanism, different clinical use case in the Russian literature. Neither has a well-documented human withdrawal syndrome in published research. But because semax is more stimulating for some users (closer to a mild cognitive enhancer) and selank is more calming, people sometimes attribute stopping-related fatigue or low mood to "withdrawal" when it might just be the absence of a stimulating effect wearing off, which is a different phenomenon than dependence. If you've been using both, it's worth stopping one at a time so you can actually tell which effects belong to which peptide.

who should be extra cautious about stopping (or starting) selank?

People on other psychiatric medications, especially SSRIs, SNRIs, or benzodiazepines, should talk to a prescribing doctor before starting or stopping selank, not because of a documented interaction in the literature (there isn't a well-characterized one), but because the combination hasn't been studied and your doctor is the one managing your actual medication risk. People with a diagnosed anxiety disorder who are using selank instead of, rather than alongside, an established treatment should be cautious about stopping abruptly if they haven't got another plan in place. This isn't a selank-specific withdrawal issue. It's the general risk of discontinuing anything that's been managing a real condition without a replacement strategy. Pregnant or breastfeeding people, and anyone with a peptide allergy or a history of unusual reactions to injectable or intranasal peptides, should treat selank the way you'd treat any understudied compound: skip it, or at minimum get a doctor's input first. None of this is unique to stopping selank specifically, but it's the context that matters most when the withdrawal literature itself is this sparse.

what should you actually do if you want to stop selank?

Here's a practical approach that doesn't require Russian to read the primary literature and doesn't require pretending we know more than we do. First, if you've used it for more than a month at daily or near-daily frequency, taper over roughly a week rather than stopping in one day. Reduce frequency (every other day, then every third day) rather than reducing the dose amount, since selank dosing units (drops or sprays) aren't finely divisible anyway. Second, track how you feel for about two weeks after your last dose, ideally with something simple like a daily 1-to-10 anxiety rating. If your numbers settle back near where they were before you started, that's consistent with what the limited evidence would predict. If they spike well above your pre-selank baseline and stay there, that's unusual and worth flagging to a doctor, not because it's expected, but because it would be new information nobody has documented yet. Third, don't source selank from anywhere that can't tell you what's actually in the vial. Peptide purity and dosing accuracy vary a lot across suppliers, and a "withdrawal" symptom is sometimes just a reaction to an inconsistent product rather than the compound itself. Selank Co reviews suppliers and points to a provider-reviewed pharmacy partner for exactly this reason: sourcing quality affects what you experience both during use and after you stop, and it's one of the few variables you can actually control given how thin the underlying research is. If you're still deciding whether to start at all, is selank worth it and selank pros and cons lay out the tradeoffs more fully before you get to the stopping question.

Frequently asked questions

Does selank cause a rebound in anxiety worse than before you started?

There's no published evidence of this. The Russian trials that exist don't include structured discontinuation follow-up, so a rebound effect specifically hasn't been ruled out, but there's also no case report or study describing one. Most informal reports describe symptoms returning to pre-treatment baseline, not exceeding it.

How long should you taper off selank before stopping completely?

No official guideline exists. A reasonable, low-risk approach for daily users of more than a few weeks is stepping down over about 3 to 7 days by reducing frequency rather than dose size. Short-term users (under two weeks) generally have little reason to taper at all based on current evidence.

Can you stop selank suddenly without any problems?

Most available evidence and user reports suggest yes, especially after short courses. There's no documented pharmacological dependence mechanism for selank. Still, because long-term discontinuation studies don't exist, a short taper after extended use is a reasonable low-cost precaution rather than a strict requirement.

Is selank withdrawal comparable to benzodiazepine withdrawal?

No. Benzodiazepine withdrawal is well-documented and can include rebound anxiety, tremor, and in severe cases seizures, driven by GABA-A receptor adaptation. Selank doesn't act primarily on that receptor system, and no comparable withdrawal syndrome has been documented for it in the literature.

Does selank interact with antidepressants or cause discontinuation issues when combined?

There's no well-characterized interaction data between selank and SSRIs, SNRIs, or other antidepressants in published studies. Anyone on psychiatric medication should talk to their prescriber before adding or stopping selank, since the combination simply hasn't been formally studied.

How long do selank's effects last after your last dose?

Selank has a short half-life, generally described in animal pharmacokinetic studies as minutes to under an hour, and detailed human PK data is limited. Most anecdotal reports describe noticeable effects fading within about a day of the last dose.

Is selank addictive or habit-forming?

No physical dependence or tolerance pattern is documented in the literature, and it isn't a controlled substance. Psychological habituation from daily routine use is possible with almost any regularly taken substance, but that's different from pharmacological addiction.

Is selank withdrawal different from semax withdrawal?

Selank and semax are different peptides (tuftsin-derived versus ACTH-derived) with different primary effects, anxiolytic versus nootropic/neuroprotective. Neither has a documented withdrawal syndrome in the literature. Stopping-related fatigue after semax may reflect loss of a stimulating effect rather than dependence, a distinct phenomenon from selank discontinuation.

Why isn't there more research on stopping selank?

Most selank research comes from Russian institutions and journals, runs 2 to 4 weeks, and focuses on symptom improvement during treatment rather than discontinuation. This research hasn't been replicated in large Western trials, so questions specifically about stopping and withdrawal remain largely unanswered by controlled studies.

What symptoms after stopping selank would be worth telling a doctor about?

New symptoms that weren't part of your original anxiety, or symptoms clearly worse than your pre-treatment baseline, especially physical ones like tremor, sweating, or a racing heart, would be unusual for selank based on current evidence and are worth flagging, since no such pattern has been documented before.

Should you stop selank before surgery or a medical procedure?

There's no specific guidance on this because selank hasn't been studied in a perioperative context. As general practice, mention any supplement or peptide you're using, including selank, to your surgical team beforehand so they have the full picture, even without documented surgical interaction data.

Does selank show up on a drug test?

Selank isn't a controlled substance and isn't part of standard drug testing panels in the US or Russia. There's no published data on detection windows because routine testing for it doesn't exist in clinical or workplace settings.

Sources

1. DrugBank Online, Selank entry: Selank is a synthetic heptapeptide derived from tuftsin, developed in Russia, not FDA approved
2. PubMed, Kolomin et al., mechanisms of Selank action: Selank affects BDNF expression and enkephalin-degrading enzyme activity as part of its proposed mechanism
3. FDA, Benzodiazepine drug class safety labeling changes: Benzodiazepines carry documented risks of physical dependence and withdrawal including rebound anxiety and seizures
4. NIH MedlinePlus, Antidepressant withdrawal information: SSRI discontinuation can cause dizziness and flu-like symptoms, particularly with shorter half-life agents
5. PubMed, Kozlovskaya et al., Selank anxiolytic effects in generalized anxiety disorder: Selank trials in Russian patients with anxiety disorders were short-duration, generally weeks, measuring on-treatment symptom scores
6. PubMed, Neuroscience and Behavioral Physiology review of Selank clinical studies: Selank clinical literature is concentrated in Russian-language journals and short trial durations without discontinuation follow-up
7. PubMed, Selank pharmacokinetics and metabolism study: Selank is rapidly metabolized with a short half-life in circulation based on animal pharmacokinetic data
8. PubMed, Semax mechanism and neuroprotective research overview: Semax is an ACTH-derived peptide studied for nootropic and neuroprotective effects, distinct from selank's tuftsin-derived anxiolytic profile